​

Accelerate Diagnostics (AXDX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Accelerate Diagnostics Revenue Highlights

Latest Revenue (Y)

$11.70M

Latest Revenue (Q)

$2.98M

Main Segment (Y)

Product

Accelerate Diagnostics Revenue by Period

Accelerate Diagnostics Revenue by Year

DateRevenueChange
2024-12-31$11.70M-2.99%
2023-12-31$12.06M-5.43%
2022-12-31$12.75M8.23%
2021-12-31$11.78M5.53%
2020-12-31$11.16M20.09%
2019-12-31$9.30M63.97%
2018-12-31$5.67M35.74%
2017-12-31$4.18M1597.97%
2016-12-31$246.00K67.35%
2015-12-31$147.00K20.49%
2014-12-31$122.00K152.67%
2013-12-31$48.28K-79.54%
2012-07-31$236.00K-78.95%
2011-07-31$1.12M-50.07%
2010-07-31$2.25M76.84%
2009-07-31$1.27M167.05%
2008-07-31$475.52K159.66%
2007-07-31$183.13K-13.90%
2006-07-31$212.70K-57.64%
2005-07-31$502.11K323.31%
2004-07-31$118.61K-86.05%
2003-07-31$850.57K30.06%
2002-07-31$653.98K-23.57%
2001-07-31$855.66K-45.41%
2000-07-31$1.57M-45.91%
1999-07-31$2.90M-60.74%
1998-07-31$7.38M195.26%
1997-07-31$2.50M19.05%
1996-07-31$2.10M-

Accelerate Diagnostics generated $11.70M in revenue during NA 2024, up -2.99% compared to the previous quarter, and up 125.83% compared to the same period a year ago.

Accelerate Diagnostics Revenue by Quarter

DateRevenueChange
2024-09-30$2.98M-0.37%
2024-06-30$2.99M2.23%
2024-03-31$2.92M-2.63%
2023-12-31$3.00M-9.06%
2023-09-30$3.30M12.94%
2023-06-30$2.92M3.88%
2023-03-31$2.81M-5.38%
2022-12-31$2.97M0.41%
2022-09-30$2.96M-23.34%
2022-06-30$3.86M30.53%
2022-03-31$2.96M-11.52%
2021-12-31$3.34M7.08%
2021-09-30$3.12M11.58%
2021-06-30$2.80M11.12%
2021-03-31$2.52M-19.01%
2020-12-31$3.11M-13.35%
2020-09-30$3.59M68.85%
2020-06-30$2.13M-9.27%
2020-03-31$2.34M-32.51%
2019-12-31$3.47M52.80%
2019-09-30$2.27M25.75%
2019-06-30$1.81M3.20%
2019-03-31$1.75M-3.95%
2018-12-31$1.82M34.46%
2018-09-30$1.35M-19.92%
2018-06-30$1.69M111.24%
2018-03-31$801.00K-62.20%
2017-12-31$2.12M155.92%
2017-09-30$828.00K18.45%
2017-06-30$699.00K31.89%
2017-03-31$530.00K1258.97%
2016-12-31$39.00K62.50%
2016-09-30$24.00K20.00%
2016-06-30$20.00K-87.73%
2016-03-31$163.00K640.91%
2015-12-31$22.00K-76.09%
2015-09-30$92.00K384.21%
2015-06-30$19.00K35.71%
2015-03-31$14.00K-82.28%
2014-12-31$79.00K393.75%
2014-09-30$16.00K23.08%
2014-06-30$13.00K-7.14%
2014-03-31$14.00K12.57%
2013-12-31$12.44K-2.81%
2013-09-30$12.80K73.57%
2013-06-20$7.37K-52.97%
2013-03-31$15.68K88.80%
2012-10-31$8.30K-33.34%
2012-07-31$12.46K-5.68%
2012-04-30$13.21K58.59%
2012-01-31$8.33K-95.88%
2011-10-31$202.01K100.08%
2011-07-31$100.97K-57.98%
2011-04-30$240.27K-23.37%
2011-01-31$313.57K-32.76%
2010-10-31$466.36K-78.41%
2010-07-31$2.16M10770.08%
2010-04-30$19.87K-60.25%
2010-01-31$49.99K221.53%
2009-10-31$15.55K-95.23%
2009-07-31$326.21K17.12%
2009-04-30$278.53K-23.59%
2009-01-31$364.49K21.23%
2008-10-31$300.65K39.50%
2008-07-31$215.53K253.92%
2008-04-30$60.90K-

Accelerate Diagnostics generated $2.98M in revenue during Q3 2024, up -0.37% compared to the previous quarter, and up 101.85% compared to the same period a year ago.

Accelerate Diagnostics Revenue Breakdown

Accelerate Diagnostics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
Service$1.48M$1.45M$1.65M$1.35M$829.00K
Product and Service, Other$-33.00K----
Product$10.22M$10.61M$11.11M$10.43M$10.34M
Other Revenue-$131.00K$154.00K$154.00K$140.00K
Accelerate Pheno--$12.60M$11.63M$11.03M

Accelerate Diagnostics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (87.59%), Service (12.70%), and Product and Service, Other (-0.28%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
Service$693.00K$356.00K$432.00K$357.00K$369.00K$356.00K$368.00K$419.00K$428.00K$385.00K$412.00K$387.00K$349.00K$315.00K$301.00K$254.00K$186.00K$188.00K$201.00K$162.00K
Product$5.11M$2.62M$2.49M$2.67M$2.93M$2.56M$2.44M$2.55M$2.53M$3.48M$2.55M$2.96M$2.77M$2.48M$2.22M$2.85M$3.40M$1.94M$2.14M$3.31M
Other Revenue---$28.00K$35.00K$68.00K-$43.00K$27.00K$43.00K$40.00K$39.00K$38.00K$31.00K$45.00K$64.00K$6.00K$32.00K$38.00K$40.00K
Accelerate Pheno----$3.26M$2.85M$2.81M$2.93M$2.93M$3.82M$2.92M$3.30M$3.08M$2.77M$2.47M$3.04M$3.58M$2.09M$2.30M$3.43M

Accelerate Diagnostics's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Product (88.06%), and Service (11.94%).

Accelerate Diagnostics Revenue Breakdown by Country

Quarterly Revenue by Country

CountryMar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18Jun 18
Service$368.00K$419.00K$428.00K$385.00K$412.00K$387.00K$349.00K$315.00K$301.00K$254.00K$186.00K$188.00K$201.00K$162.00K$128.00K$111.00K$57.00K$44.00K$24.00K-
Accelerate Pheno$2.81M$2.93M$2.93M$3.82M$2.92M$3.30M$3.08M$2.77M$2.47M$3.04M$3.58M$2.09M$2.30M$3.43M$2.22M$1.78M$1.71M$1.79M$1.32M$1.67M
Other Revenue-$43.00K$27.00K$43.00K$40.00K$39.00K$38.00K$31.00K$45.00K$64.00K$6.00K$32.00K$38.00K$40.00K$50.00K$29.00K$45.00K$35.00K$30.00K$27.00K
Product$2.44M$2.55M$2.53M$3.48M$2.55M$2.96M$2.77M$2.48M$2.22M$2.85M$3.40M$1.94M$2.14M$3.31M$2.14M$1.70M$1.69M$1.78M$1.33M-

Accelerate Diagnostics's latest quarterly revenue breakdown by geography, as of Mar 23: Accelerate Pheno (50.00%), Product (43.46%), and Service (6.54%).

Accelerate Diagnostics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ITGRInteger$1.72B$746.27M
CNMDCONMED$1.31B$316.70M
LIVNLivaNova$1.25B$318.11M
AVNSAvanos Medical$687.80M$170.40M
AORTArtivion$388.54M$95.78M
KIDSOrthoPediatrics$204.73M$52.80M
AXGNAxoGen$187.34M$48.64M
ANIKAnika Therapeutics$166.66M$38.75M
SRDXSurmodics$126.08M$29.92M
LUNGPulmonx$83.79M$20.39M
NPCENeuroPace$79.91M$21.06M
SGHTSight Sciences$79.87M$20.16M
IRMDIRadimed$73.24M$18.33M
CVRXCVRx$51.29M$13.37M
AXDXAccelerate Diagnostics$11.70M$2.98M
OFIXOrthofix Medical-$198.62M

AXDX Revenue FAQ

What is Accelerate Diagnostics’s yearly revenue?

Accelerate Diagnostics's yearly revenue for 2024 was $11.7M, representing a decrease of -2.99% compared to 2023. The company's yearly revenue for 2023 was $12.06M, representing a decrease of -5.43% compared to 2022. AXDX's yearly revenue for 2022 was $12.75M, representing an increase of 8.23% compared to 2021.

What is Accelerate Diagnostics’s quarterly revenue?

Accelerate Diagnostics's quarterly revenue for Q3 2024 was $2.98M, a -0.37% decrease from the previous quarter (Q2 2024), and a -9.82% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $2.99M, a 2.23% increase from the previous quarter (Q1 2024), and a 2.23% increase year-over-year (Q2 2023). AXDX's quarterly revenue for Q1 2024 was $2.92M, a -2.63% decrease from the previous quarter (Q4 2023), and a 3.88% increase year-over-year (Q1 2023).

What is Accelerate Diagnostics’s revenue growth rate?

Accelerate Diagnostics's revenue growth rate for the last 3 years (2022-2024) was -8.27%, and for the last 5 years (2020-2024) was 4.77%.

What are Accelerate Diagnostics’s revenue streams?

Accelerate Diagnostics's revenue streams in c 24 are Service, Product and Service, Other, and Product. Service generated $1.48M in revenue, accounting 12.70% of the company's total revenue, up 2.14% year-over-year. Product and Service, Other generated $-33K in revenue, accounting -0.28% of the company's total revenue Product generated $10.22M in revenue, accounting 87.59% of the company's total revenue, down -3.69% year-over-year.

What is Accelerate Diagnostics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Accelerate Diagnostics was Product. This segment made a revenue of $10.22M, representing 87.59% of the company's total revenue.